Unibest

Pharmaceutical intermediates

Nebivolol Hydrochloride Intermediates

4 pharmaceutical intermediates for Nebivolol Hydrochloride. Indication: Hypertension.

提交项目All intermediates

About Nebivolol Hydrochloride

Originator
Johnson & Johnson Innovation Pharmaceuticals
Indication
Hypertension
Approved Date
01/01/1997

Available intermediates

4 intermediates currently listed for Nebivolol Hydrochloride. Request specifications, documentation or a quotation for any item below.

Nebivolol Hydrochloride intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(±)-(R*, R* und R*, S*)-6-Fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran129050-26-6//
(2S, 2’S)-6-Fluoro-2-(2’-oxiranyl)chromane129050-23-3//
(+)-(S,R)-6-fluoro-3,4-dihydro-2-(2-oxiranyl)-2H-1-benzopyran197706-51-7//
(R)-6-Fluoro-2-[(R)-2-oxiranyl]chromane197706-50-6//

Other programs under N

Nafamostat mesylateNemorexantNeratinib/ PyrotinibNilotinibNintedanib EsylateNiraparib

Building toward Nebivolol Hydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →